Benitec Biopharma Inc. (BNTC) stock
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.15−0.39 (-4.57%)
Close on Nov 17, 2026Market cap $284.29MP/E –Yield –
Benitec Biopharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Benitec Biopharma's price to sales ratio was 429.5× on Jan 31, 2024, against 48.9× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 429.5× | −64.2 |
| 2023 | Dec 29, 2023 | 493.7× | +405.4 |
| 2022 | Oct 31, 2022 | 88.3× | +49.9 |
| 2020 | Jul 31, 2020 | 38.4× | −2.7 |
| 2019 | Dec 31, 2019 | 41.1× | – |
See a number that looks wrong?